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Abstract
Background: Mouse B78 cells and Chinese hamster ovary (CHO) cells are important to the study of HSV-1 entry
because both are resistant to infection at the level of viral entry. When provided with a gD-receptor such as nectin-1,
these cells support HSV-1 entry by an endocytosis pathway. Treating some viruses bound to cells with the fusogen
polyethylene glycol (PEG) mediates viral fusion with the cell surface but is insufficient to rescue viral entry. It is
unclear whether PEG-mediated fusion of HSV with the plasma membrane of B78 or CHO cells results in successful
entry and infection.
Findings: Treating HSV-1 bound to B78 or CHO cells with PEG allowed viral entry as measured by virus-induced
beta-galactosidase activity. Based on the mechanism of PEG action, we propose that entry likely proceeds by
direct fusion of HSV particles with the plasma membrane. Under the conditions tested, PEG-mediated infection
of CHO cells progressed to the level of HSV late gene expression, while B78 cells supported HSV DNA replication.
We tested whether proteolysis or acidification of cell-bound virions could trigger HSV fusion with the plasma
membrane. Under the conditions tested, mildly acidic pH of 5–6 or the protease trypsin were not capable of
triggering HSV-1 fusion as compared to PEG-treated cell-bound virions.
Conclusions: B78 cells and CHO cells, which typically endocytose HSV prior to viral penetration, are capable of
supporting HSV-1 entry via direct penetration. HSV capsids delivered directly to the cytosol at the periphery of
these cells complete the entry process. B78 and CHO cells may be utilized to screen for factors that trigger entry
as a consequence of fusion of virions with the cell surface, and PEG treatment can provide a necessary control.
Keywords: Herpesviruses, Herpes simplex virus, Viral entry, Virus-cell fusion, Membrane fusion, Endocytosis,
Receptors, Low pH
Background
To accomplish entry via virus-cell membrane fusion, vi-
ruses depend on one or more cellular triggers such as
endosomal pH, receptor engagement, and/or enzymatic
cleavage [1–6]. The host requirements for herpesviral fu-
sion and entry are incompletely defined. Herpes simplex
virus (HSV) binds to a cellular receptor such as nectin-1
or HVEM. This interaction is essential, but it is not clear
if it is sufficient for fusion and entry [7, 8]. There is
mounting evidence for additional cellular cues for HSV
entry such as intracellular low pH [9–14] and receptors
that bind either gB [15–17] or gH [18–21].
HSV is able to traverse a pH-dependent, endocytic path-
way [9]. The endosomal route is utilized in many cell lines
including the model cell lines, CHO-nectin-1 and B78-
nectin-1 [9, 10, 12, 22–25]. HSV entry into several human
epithelial lines including epidermal keratinocytes occurs
via a low pH-dependent pathway similar to CHO-receptor
cells [9, 10, 21, 25–27]. Entry into human neuronal SY5Y
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cells and human epidermal cell line A431 proceeds via a
pathway similar to that in B78-receptor cells [10, 24]. In
addition, HSV enters several human neuronal cell types
and model Vero cells by direct, pH-independent pene-
tration at the plasma membrane [10, 28–31]. An emer-
ging theme for herpesvirus entry is the utilization of
endocytic and non-endocytic routes in a cell type-
dependent manner [9, 10, 32–37].
Receptor-deficient cells have been valuable tools for
understanding HSV entry. For example, the screening of
expression libraries in CHO cells was a key approach in
the identification of several cellular entry factors and re-
ceptors for HSV [15, 38–41]. B78 and CHO cells are
both resistant to HSV-1 entry [42, 43]. However, when
provided with a gD-receptor such as nectin-1, these cells
support HSV entry by an endocytosis pathway.
The full complement of cellular factors that are suffi-
cient for HSV entry is not clear. Receptor-negative cells
that normally support entry by endocytosis are excellent
tools to screen for factors that trigger HSV-cell fusion.
In order for such a system to be useful, entry that results
from fusion with the plasma membrane must be detect-
able. Since HSV entry pathway varies with cell type, it is
possible that cells that typically support HSV capsid re-
lease and penetration from an endocytic compartment
may not properly target a capsid that appears in the cell
periphery. In fact, Semliki Forest Virus, which normally
enters by endocytosis, can be artificially fused with the
plasma membrane of CHO cells as detected by electron
microscopy. However, the de-enveloped SFV capsid re-
mains trapped in the cell periphery and complete entry
and infection does not occur [44]. The chemical fusogen,
polyethylene glycol (PEG) has been utilized to artificially
fuse HSV with cells to analyze envelope glycoprotein func-
tion [45–47]. PEG has been underutilized as a means to
address cellular factors involved in HSV entry and fusion.
Here, we use PEG-mediated fusion to determine that HSV
receptor-negative B78 and CHO cells are able to support
the plasma membrane route of entry. We then use this
model system to evaluate the ability of a protease and low
pH to trigger virus-cell fusion.
Results and discussion
B78H1 Gal11 cells (referred to as B78 cells in this study)
are mouse melanoma cells derived from parental B78H1
cells, which are resistant to HSV entry. B78 cells are sta-
bly transformed with the Escherichia coli lacZ gene
under the control of the HSV ICP4 promoter. B78C10
cells (referred to as B78-nectin-1 cells in this study) sta-
bly express the lacZ gene and the human gD-receptor
nectin-1. Nectin-1 renders B78 cells susceptible to HSV
entry. CHO-IEβ8 cells are a hamster cell line derived
from the parental CHO-K1 cell line and are stably trans-
formed with the Escherichia coli lacZ gene under the
control of the HSV ICP4 promoter. CHO-nectin-1
(M3A) cells are CHO-IEβ8 cells stably transformed with
the human nectin-1 gene. The beta-galactosidase re-
porter assay is widely used as an indicator of HSV entry.
As expected [42, 43], adding HSV-1 at an MOI of 10 to
wild type B78 or CHO cells did not result in detectable viral
entry (Fig. 1a and c) as measured by beta-galactosidase ac-
tivity. PEG 6000 solid (Sigma) was melted in an Amsco
autoclave (STERIS, Mentor, OH). A 1 g/ml solution of PEG
6000 in serum-free cell culture medium was incubated at
37 °C until dissolved. Ice-cold HSV-1 strain KOS was added
to confluent cell monolayers (MOI of 10) for 2 h at 4 °C to
allow for cell binding. Cultures were washed with warm
PBS. Cell-bound virus was treated with PEG 6000 or mock-
treated. PEG solution was added to the cell surface for 30 s,
and then cells were rinsed thrice with warm PBS. Complete
cell culture medium was then added to cells. When PEG
6000 was added to HSV-1 bound to the surface of either
B78 or CHO cells, viral entry was detected as determined
by beta-galactosidase activity (Fig. 1a and c). PEG has also
been shown to mediate infection of swine testis (ST) cells,
which are resistant to HSV-1 entry [48]. The mode of HSV-
1 entry into ST cells has not been established. In the B78
and CHO cells used in this study, following membrane
fusion, tegument VP16 is translocated to the nucleus and
induces beta-galactosidase expression driven by the ICP4
promoter. These results suggest that PEG successfully trig-
gered fusion between the viral envelope and the plasma
membrane. When an appropriate gD-receptor is present,
the subcellular site of fusion in both B78 and CHO cells
is an internal, endosomal membrane. Thus, if appropri-
ate conditions are provided, HSV-1 can fuse with the
plasma membrane of cells that typically support viral
endocytosis. This fusion can be detected by down-
stream reporter gene expression.
If the enhanced beta-galactosidase signal in the PEG-
treated samples (Fig. 1a) is due to HSV-1 entry, then
adding increasing amounts of HSV-1 should result in a
concomitant increase in reporter expression. Indeed,
beta-galactosidase activity increased in a virus dose-
dependent manner when MOIs ranging from 0 to 10
were tested in the PEG experiment on wild type B78
and CHO cells (Fig. 1b and d). Importantly, PEG treat-
ment of CHO or B78 cells in the absence of virus did
not result in beta-galactosidase activity above back-
ground (MOI of 0 in Fig. 1b and d). To our knowledge,
this is the first demonstration of PEG rescuing HSV in-
fection of receptor-negative CHO and B78 cells. PEG
has been used previously to rescue the fusion activity of
fusion-dead virus mutants [45–47]. We gauged the effi-
ciency of PEG-triggered entry as compared to gD-
receptor-mediated entry via endocytosis. In general,
PEG-mediated entry into the receptor-negative cells
was less efficient than entry into the corresponding cells
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expressing the gD-receptor nectin-1 (Fig. 1b and d). At all
MOIs tested for CHO cells and at the higher MOIs of 5
and 10 for the B78 cells, the nectin-1 expressing cells sup-
ported entry ~ 9 to 12-times more effectively than PEG-
induced fusion in the respective receptor-negative cells.
Furthermore, PEG-mediated entry into B78 cells at the
lowest MOIs tested (0.5 and 1) was ~ 40 to 70 times less
efficient than entry into B78-nectin-1 cells (Fig. 1b). These
differences may be even greater when comparing fully
entry-competent viral samples (if these could be obtained),
as it is possible that PEG fusion might permit infection by
virions that would otherwise be defective for a receptor-
dependent entry pathway. In contrast to HSV-1, HSV-2
strains successfully enter wild type CHO cells [41, 42], so
it is of future interest to determine the effect of PEG treat-
ment on HSV-2.
We microscopically examined the effect of PEG treat-
ment on HSV infectivity of receptor-negative cells. As
expected, addition of HSV-1 alone to wild type B78 or
CHO cells resulted in no detectable infected cells (Fig. 2b
and f), virtually indistinguishable from uninfected cells
(Fig. 2a and e). This is consistent with the resistance of
B78 cells and CHO cells to HSV-1 entry. PEG treatment
of HSV-1 bound to B78 cells followed by 24 h infection
resulted in HSV-antigen positive, single cells and small
clusters of cells, as detected by immunoperoxidase stain-
ing with an anti-HSV polyclonal antibody (Fig. 2d). This
is visual evidence that PEG mediates HSV entry into
receptor-negative B78 cells. Treatment with PEG alone
did not result in HSV antigen staining in this assay
(Fig. 2c). HSV forms large plaques comprised of dozens
of infected cells on B78 cells that express gD-receptors
such as nectin-1 and HVEM, consistent with a gD-
receptor allowing entry [43]. The single-infected cells
and small plaques in the PEG treated samples (Fig. 2d)
are consistent with the requirement of gD-receptors to
mediate spread between B78 cells [49].
In contrast to the B78 cell result, PEG treatment of
HSV-1 bound to CHO cells followed by 24 h infection did
not result in detection of HSV-antigen positive cells
(Fig. 2h). Thus, although PEG mediates entry of HSV-1
into receptor-negative CHO cells as measured by reporter
gene expression (Fig. 1), synthesis of viral antigens is not
detected by immunoperoxidase staining of fixed cells at
Fig. 1 PEG-mediated entry of HSV-1 into cells that are resistant to entry and that normally mediate entry via an endocytosis pathway. HSV-1 strain
KOS was bound to B78 cells (a) or CHO cells (c) (MOI of 10) for 2 h at 4 °C. Cell bound virus was treated with PEG 6000 (+ PEG) or mock-treated
(− PEG). At 7 h post-infection, beta-galactosidase activity was detected as an indication of viral entry [74]. b, d HSV-1 KOS was bound to B78 and
B78-nectin-1 cells (b) or CHO and CHO-nectin-1 cells (d) for 2 h at 4 °C at the indicated MOIs ranging from 0.5 to 10. B78 and CHO cell samples were
treated with PEG and B78-nectin-1 and CHO-nectin-1 samples were mock treated. Beta-galactosidase activity was measured at 7 h p.i. b, d To allow a
more direct comparison between samples of disparate reactivity, a fraction of the B78-nectin-1 and CHO-nectin-1 samples was measured. Values
shown represent the beta-galactosidase activity from equivalent cell numbers. Each value is the mean of quadruplicate determinations with standard
deviation. One representative experiment of at least three independent experiments is shown
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24 h. CHO cells that express gD-receptors do not support
wild type HSV-1 plaque formation [39, 42]. Together with
Fig. 1c and d, these results support the notion that beta-
galactosidase reporter gene expression is more sensitive
for detecting entry into CHO cells than is staining cells
for HSV-specific antigen. Interestingly, treatment of CHO
cells with PEG alone caused noticeable cell-cell fusion
(Fig. 2g). Similar fusion was not detected with B78 cells
(Fig. 2c). That CHO cells are prone to fusion is important
for interpreting results from HSV cell-cell fusion assays, in
which CHO cells have been widely used [50–53]. In fact,
when CHO cell preparations are mixed in fusion assays
the background fusion can be high ([50]; data not shown).
To explore how far infection progresses following
PEG fusion of HSV-1 with B78 and CHO cells, viral
gene expression and replication were measured by re-
verse transcriptase-qPCR with the indicated primers
(Table 1). PEG-mediated entry of HSV-1 into B78 and
CHO cells resulted in detectable expression of HSV-1
mRNAs representative of the immediate early (ICP27),
early (thymidine kinase), and late (gC) gene classes
(Fig. 3a and b). Detection of these specific proteins was
not attempted. If viral proteins are indeed synthesized
in PEG-treated CHO cells, the levels are likely too low
to be detected by the antigen staining in Fig. 2. How-
ever, HSV-induced beta-galactosidase is clearly pro-
duced in these cells (Fig. 1).
PEG fusion of HSV-1 with B78 cells resulted in de novo
synthesized viral genomic DNA as detected by qPCR
(Fig. 4a). However, when an MOI as high as 30 was tested,
extracellular progeny virions above the input inoculum
were not detected. PEG-induced HSV-1 entry into CHO
cells did not result in detectable viral DNA replication
(Fig. 4b). CHO cells expressing the receptor HVEM are
reportedly permissive for viral replication [39]. PEG-
mediated entry into CHO cells at higher MOI might result
in detectable HSV-1 replication. Likewise higher MOI in
B78 cells might result in egress of progeny virions. HSV-1
infection of the permissive control cell line, B78-nectin-1
(MOI of 10), resulted in detectable viral DNA both inside
the infected cell and in the extracellular medium (Fig. 4c).
This is consistent with the ability of B78-nectin-1 cells to
support HSV-1 plaque formation. Alternatively, nectin-1
may somehow rescue a post-replication defect in HSV-
infected B78 cells. Thus, PEG fusion leads to successful
entry, albeit at lower efficiency than nectin-1-mediated
endocytosis, consistent with the results from Fig. 1. To-
gether the results suggest that direct deposit of the nu-
cleocapsid into the cytosol at the plasma membrane of
CHO or B78 cells results in successful entry leading to
viral gene expression or replication, respectively.
Cellular receptors that bind to gD are required for HSV
entry, but it is not known whether they are sufficient.
Since direct fusion of HSV-1 with receptor-negative cells
results in entry without the need for endocytosis (Fig. 1),
we were able to directly test potential triggers of virus-cell
fusion. During entry of several viruses, cleavage of viral
surface proteins by cellular endosomal proteases is a
Table 1 Primers used in this study











aPrimers modified from reference [76] to remove dimers and hairpins
Fig. 2 Microscopic analysis of the effect of PEG 6000 on HSV-1 infection of receptor-negative cells. B78 cells (a-d) or CHO cells (e-h) were infected
with HSV-1 strain KOS (MOI of 10) (b, d, f, h) or remained uninfected (a, c, e, g) for 2 h at 4 °C. Cultures were treated with PEG 6000 (c, d, g, h) or
mock-treated (a, b, e, f). At 24 h post-infection (p.i.), cultures were fixed with ice-cold methanol-acetone solution (2:1 ratio) for 20 min at −20 °C
and air dried. HSV antigen-positive cells were detected by immunoperoxidase staining with anti-HSV polyclonal antibody HR50 (Fitzgerald Industries,
Concord, MA) [75]. Magnification, 5X
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requirement for entry [4, 6, 54, 55]. In vitro protease treat-
ment of viral particles can sometimes substitute for the
cleavage during entry, and has been used for evidence that
proteolysis is required for entry. We tested whether tryp-
sin treatment of HSV-1 could trigger fusion with the
surface of B78 cells as measured by beta-galactosidase ex-
pression. CHO cells were omitted from this analysis be-
cause of their sensitivity to even the lowest concentrations
of trypsin tested (data not shown). HSV-1 was bound to
the B78 plasma membrane at 4 °C, and then treated with
increasing concentrations of trypsin. For limited proteoly-
sis experiments, proteases are often added at 4 °C at which
they are active ([56], unpublished data). Trypsin treatment
under these conditions did not result in detectable viral
entry (Fig. 5a). Importantly, control PEG treatment of
cell-bound HSV-1 induced entry. In addition, inhibitors of
cathepsins B and L do not block HSV entry [57]. We can-
not discard the possibility that a distinct proteolytic event
that is not mimicked by the trypsin treatments tested may
yet play a role in HSV entry.
HSV requires intracellular low pH in a cell-specific
manner [9, 11, 12, 22, 23]. Agents that alter endosomal
pH such as bafilomycin A1 and ammonium chloride in-
hibit HSV entry into epithelial cells but not neurons [10].
HSV gB is triggered by low pH to undergo conformational
changes [14, 58–62]. We have proposed that pH acti-
vates gB to trigger membrane fusion in part because
the antigenic profile of low pH-treated gB is similar to
that of the highly fusogenic gB present in fusion-from-
without strains of HSV [63]. The entry requirement for
low pH is shared by several herpesviruses, often in a
cell-dependent manner [36, 64–66]. However, direct
demonstration that acid pH triggers herpesviral fusion has
remained elusive. We therefore asked whether low pH is
able to directly trigger fusion of the HSV-1 envelope with
the plasma membrane of a target cell. HSV-1 was bound
to the B78 cell surface and then treated with different
pHs. Treatment with pHs of 5.7 or 4.5 did not trigger
HSV-1 entry above the background level detected when
cells were treated with PEG in the absence of HSV
(Fig. 5b). PEG treatment of cell-bound HSV-1 allowed
entry and was included as a critical control. The current
experiments suggest that proteolysis or low pH alone is
not sufficient for entry. One explanation may be that a
Fig. 3 PEG-mediated entry leads to HSV-1 gene expression. At 6 or
24 h following either PEG treatment of HSV-1 bound to (a) B78 or (b)
CHO cells or (c) following HSV-1 infection of B78-nectin-1 cells, RNA
was extracted with TRIzol (Ambion). Following DNase treatment, first-
strand cDNA was synthesized from 1.75 micrograms of total RNA using
SuperScript VILO (Invitrogen). Equal volumes of cDNA were used to
quantify HSV-1 gene ICP27, thymidine kinase (TK) and gC transcripts
with Sso Advanced Sybr Green SuperMix (Bio-Rad), using a Bio-Rad
CFX96 Real Time System. The quantity of HSV-1 mRNAs, normalized to
cellular GAPDH, is shown relative to mRNA from 6 h post-PEG fusion
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Fig. 4 Detection of HSV-1 replication following PEG fusion. At 6 or 24 h following PEG treatment of HSV-1 bound to (a) B78 or (b) CHO cells (MOI
of 10), DNA was extracted from cells with PureGene Kit (Qiagen) or from supernatant (Extracellular) with QIAamp DNA Blood Mini Kit (Qiagen).
A standard curve for the assay was generated using known numbers of copies of a plasmid containing the HSV-1 ICP22 coding region diluted
in glycogen. (c) Permissive control B78-nectin-1 cells were infected with HSV-1 for 24 h and processed as in panels a and b. 2.18E + 03 HSV-1
DNA genome copies were detected in the extracellular sample
A
B
Fig. 5 Inability of protease or low pH treatments alone to trigger fusion with the plasma membrane of entry-resistant cells. HSV-1 KOS was bound
to B78 cells (MOI of 10) for 2 h at 4 °C. a Confluent cell monolayers were chilled at 4 °C and washed with ice-cold PBS. HSV-1 strain KOS in
bicarbonate-free culture medium supplemented with 20 mM Hepes and 0.2 % BSA was added at an MOI of 10 for 2 h at 4 °C. Monolayers were
rinsed with ice-cold PBS, and then PBS containing different concentrations of trypsin was added to cells for 25 min at 4 °C. Trypsinization was
halted by addition of soybean trypsin inhibitor (8000-16,000 BAEE units; GIBCO-BRL) and 5 % fetal bovine serum for 15 min at room temperature.
Complete cell culture medium was added, and cultures were incubated for 7 h at 37 °C. b Serum-free, bicarbonate-free culture medium with
0.2 % BSA and 5 mM (each) HEPES (Life Technologies), 2-(N-morpholino)ethanesulfonic acid (MES; Sigma), and sodium succinate (Sigma) was
adjusted with HCl to achieve pHs ranging from 7.0 to 4.5 [69]. Confluent cell monolayers were chilled at 4 °C and washed with ice-cold PBS.
HSV-1 strain KOS was added at an MOI of 10 for 2 h at 4 °C. Cells were washed with warm PBS. Warmed media adjusted to different pHs were
added. Samples were incubated at 37 °C for 10 min. A pre-titrated amount of NaOH was added to return each sample to pH 7.4. Complete cell
culture medium was added, and cultures were incubated for 7 h at 37 °C. Each value is the mean of quadruplicate determinations with standard deviation.
Representative experiments of at least three independent experiments are shown
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cascade of interactions with multiple cellular factors is ne-
cessary for fusion. The sequence of these interactions may
also be critical.
Soluble, membrane-truncated, gD-receptors can also
mediate HSV entry into B78 and CHO receptor-negative
cells, but it is not known whether entry occurs at the
plasma membrane [13, 67]. In fact, CHO cells endocytose
herpes simplex virions and target them to a degradative
pathway in the absence of known membrane-bound gD-
receptors [11], so soluble gD-receptors may mediate entry
via a CHO endosomal compartment. The current study
cannot rule out that PEG treatment may somehow trigger
fusion with the endosomal membrane. However, this is
unlikely because PEG was added when virions were bound
to the cell surface, and PEG causes fusion by complete
mixing of the inner and outer leaflets of both membranes.
To begin to address the mechanism of PEG-mediated fu-
sion, we tested the ability of PEG to rescue the infectivity
of cell-bound HSV-1 that was inactivated by sodium cit-
rate buffer (pH 3.0). Low pH has long been known to
inactivate HSV, but the mechanism of inactivation is not
known [9, 59, 68–70]. PEG failed to rescue the inactivated
virions as measured by beta-galactosidase reporter expres-
sion for reasons that are not clear (data not shown). Inter-
estingly, this contrasts with the PEG rescue of HSV-1
mutants that lack either gD or gB [46, 47]. One explan-
ation of our results is that PEG substitutes for a specific
step(s) in the HSV fusion process and that PEG works
together with the viral envelope to mediate full fusion.
Under the conditions tested, low pH or trypsin were not
capable of triggering HSV-1 fusion. This may suggest that
neither is sufficient to substitute for the presence of a gD-
receptor. It is possible that a combination of multiple host
cell factors is necessary for HSV-1 fusion [3, 71–73]. Thus
a sequential application of low pH, protease, and/or gD-
receptors may be needed to mediate fusion of HSV-1 with
the surface of receptor-negative cells. We demonstrate that
B78 and CHO cells can be employed for such studies be-
cause PEG treatment of HSV-1 bound to cells likely results
in fusion with the plasma membrane of these cells. Once
identified, candidate molecules that permit HSV to fuse
with the surface of B78 or CHO cells would be tested and
confirmed in more physiologically relevant human cells.
Conclusions
B78 cells and CHO cells, which typically endocytose
HSV prior to viral penetration, are capable of supporting
HSV-1 entry via direct penetration and may be utilized
to screen for factors required for fusion of virions with
the cell surface. PEG treatment can provide a needed
control because it artificially fuses HSV with the host
cell and results in HSV gene expression, and in the case
of B78 cells, detectable viral replication. Compared to
control entry mediated by PEG, the protease and pH
conditions tested did not mediate penetration of HSV-1
at the cell surface of receptor-negative cells. One explan-
ation is that a cascade of interactions with multiple cel-
lular factors is likely necessary for fusion.
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